2021-2027 Global and Regional Animal Drug Compounding Industry Status and Prospects Professional Market Research Report Standard Version
Date: Dec-2021 | Id: MACRC-73284 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Animal Drug Compounding market was valued at 794.14 Million USD in 2020 and will grow with a CAGR of 6.01% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy. By Market Verdors: Triangle Compounding Pharmacy Lorraines Pharmacy Medisca Diamondback Drugs ESSENTIAL PHARMACY COMPOUNDING VET By Types: Anti-Infective Agents Hormones and Substitutes Anti-Inflammatory Agents By Applications: Veterinary Hospitals Veterinary Clinics Veterinary Diagnostic Centers Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Animal Drug Compounding Market Size Analysis from 2022 to 2027 1.5.1 Global Animal Drug Compounding Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Animal Drug Compounding Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Animal Drug Compounding Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Animal Drug Compounding Industry Impact Chapter 2 Global Animal Drug Compounding Competition by Types, Applications, and Top Regions and Countries 2.1 Global Animal Drug Compounding (Volume and Value) by Type 2.1.1 Global Animal Drug Compounding Consumption and Market Share by Type (2016-2021) 2.1.2 Global Animal Drug Compounding Revenue and Market Share by Type (2016-2021) 2.2 Global Animal Drug Compounding (Volume and Value) by Application 2.2.1 Global Animal Drug Compounding Consumption and Market Share by Application (2016-2021) 2.2.2 Global Animal Drug Compounding Revenue and Market Share by Application (2016-2021) 2.3 Global Animal Drug Compounding (Volume and Value) by Regions 2.3.1 Global Animal Drug Compounding Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Animal Drug Compounding Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Animal Drug Compounding Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Animal Drug Compounding Consumption by Regions (2016-2021) 4.2 North America Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) 4.10 South America Animal Drug Compounding Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Animal Drug Compounding Market Analysis 5.1 North America Animal Drug Compounding Consumption and Value Analysis 5.1.1 North America Animal Drug Compounding Market Under COVID-19 5.2 North America Animal Drug Compounding Consumption Volume by Types 5.3 North America Animal Drug Compounding Consumption Structure by Application 5.4 North America Animal Drug Compounding Consumption by Top Countries 5.4.1 United States Animal Drug Compounding Consumption Volume from 2016 to 2021 5.4.2 Canada Animal Drug Compounding Consumption Volume from 2016 to 2021 5.4.3 Mexico Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 6 East Asia Animal Drug Compounding Market Analysis 6.1 East Asia Animal Drug Compounding Consumption and Value Analysis 6.1.1 East Asia Animal Drug Compounding Market Under COVID-19 6.2 East Asia Animal Drug Compounding Consumption Volume by Types 6.3 East Asia Animal Drug Compounding Consumption Structure by Application 6.4 East Asia Animal Drug Compounding Consumption by Top Countries 6.4.1 China Animal Drug Compounding Consumption Volume from 2016 to 2021 6.4.2 Japan Animal Drug Compounding Consumption Volume from 2016 to 2021 6.4.3 South Korea Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 7 Europe Animal Drug Compounding Market Analysis 7.1 Europe Animal Drug Compounding Consumption and Value Analysis 7.1.1 Europe Animal Drug Compounding Market Under COVID-19 7.2 Europe Animal Drug Compounding Consumption Volume by Types 7.3 Europe Animal Drug Compounding Consumption Structure by Application 7.4 Europe Animal Drug Compounding Consumption by Top Countries 7.4.1 Germany Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.2 UK Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.3 France Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.4 Italy Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.5 Russia Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.6 Spain Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.7 Netherlands Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.8 Switzerland Animal Drug Compounding Consumption Volume from 2016 to 2021 7.4.9 Poland Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 8 South Asia Animal Drug Compounding Market Analysis 8.1 South Asia Animal Drug Compounding Consumption and Value Analysis 8.1.1 South Asia Animal Drug Compounding Market Under COVID-19 8.2 South Asia Animal Drug Compounding Consumption Volume by Types 8.3 South Asia Animal Drug Compounding Consumption Structure by Application 8.4 South Asia Animal Drug Compounding Consumption by Top Countries 8.4.1 India Animal Drug Compounding Consumption Volume from 2016 to 2021 8.4.2 Pakistan Animal Drug Compounding Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Animal Drug Compounding Market Analysis 9.1 Southeast Asia Animal Drug Compounding Consumption and Value Analysis 9.1.1 Southeast Asia Animal Drug Compounding Market Under COVID-19 9.2 Southeast Asia Animal Drug Compounding Consumption Volume by Types 9.3 Southeast Asia Animal Drug Compounding Consumption Structure by Application 9.4 Southeast Asia Animal Drug Compounding Consumption by Top Countries 9.4.1 Indonesia Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.2 Thailand Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.3 Singapore Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.4 Malaysia Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.5 Philippines Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.6 Vietnam Animal Drug Compounding Consumption Volume from 2016 to 2021 9.4.7 Myanmar Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 10 Middle East Animal Drug Compounding Market Analysis 10.1 Middle East Animal Drug Compounding Consumption and Value Analysis 10.1.1 Middle East Animal Drug Compounding Market Under COVID-19 10.2 Middle East Animal Drug Compounding Consumption Volume by Types 10.3 Middle East Animal Drug Compounding Consumption Structure by Application 10.4 Middle East Animal Drug Compounding Consumption by Top Countries 10.4.1 Turkey Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.3 Iran Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.5 Israel Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.6 Iraq Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.7 Qatar Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.8 Kuwait Animal Drug Compounding Consumption Volume from 2016 to 2021 10.4.9 Oman Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 11 Africa Animal Drug Compounding Market Analysis 11.1 Africa Animal Drug Compounding Consumption and Value Analysis 11.1.1 Africa Animal Drug Compounding Market Under COVID-19 11.2 Africa Animal Drug Compounding Consumption Volume by Types 11.3 Africa Animal Drug Compounding Consumption Structure by Application 11.4 Africa Animal Drug Compounding Consumption by Top Countries 11.4.1 Nigeria Animal Drug Compounding Consumption Volume from 2016 to 2021 11.4.2 South Africa Animal Drug Compounding Consumption Volume from 2016 to 2021 11.4.3 Egypt Animal Drug Compounding Consumption Volume from 2016 to 2021 11.4.4 Algeria Animal Drug Compounding Consumption Volume from 2016 to 2021 11.4.5 Morocco Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 12 Oceania Animal Drug Compounding Market Analysis 12.1 Oceania Animal Drug Compounding Consumption and Value Analysis 12.2 Oceania Animal Drug Compounding Consumption Volume by Types 12.3 Oceania Animal Drug Compounding Consumption Structure by Application 12.4 Oceania Animal Drug Compounding Consumption by Top Countries 12.4.1 Australia Animal Drug Compounding Consumption Volume from 2016 to 2021 12.4.2 New Zealand Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 13 South America Animal Drug Compounding Market Analysis 13.1 South America Animal Drug Compounding Consumption and Value Analysis 13.1.1 South America Animal Drug Compounding Market Under COVID-19 13.2 South America Animal Drug Compounding Consumption Volume by Types 13.3 South America Animal Drug Compounding Consumption Structure by Application 13.4 South America Animal Drug Compounding Consumption Volume by Major Countries 13.4.1 Brazil Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.2 Argentina Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.3 Columbia Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.4 Chile Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.5 Venezuela Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.6 Peru Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Animal Drug Compounding Consumption Volume from 2016 to 2021 13.4.8 Ecuador Animal Drug Compounding Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Animal Drug Compounding Business 14.1 Triangle Compounding Pharmacy 14.1.1 Triangle Compounding Pharmacy Company Profile 14.1.2 Triangle Compounding Pharmacy Animal Drug Compounding Product Specification 14.1.3 Triangle Compounding Pharmacy Animal Drug Compounding Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Lorraines Pharmacy 14.2.1 Lorraines Pharmacy Company Profile 14.2.2 Lorraines Pharmacy Animal Drug Compounding Product Specification 14.2.3 Lorraines Pharmacy Animal Drug Compounding Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Medisca 14.3.1 Medisca Company Profile 14.3.2 Medisca Animal Drug Compounding Product Specification 14.3.3 Medisca Animal Drug Compounding Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Diamondback Drugs 14.4.1 Diamondback Drugs Company Profile 14.4.2 Diamondback Drugs Animal Drug Compounding Product Specification 14.4.3 Diamondback Drugs Animal Drug Compounding Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 ESSENTIAL PHARMACY COMPOUNDING VET 14.5.1 ESSENTIAL PHARMACY COMPOUNDING VET Company Profile 14.5.2 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Product Specification 14.5.3 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Animal Drug Compounding Market Forecast (2022-2027) 15.1 Global Animal Drug Compounding Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Animal Drug Compounding Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Animal Drug Compounding Value and Growth Rate Forecast (2022-2027) 15.2 Global Animal Drug Compounding Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Animal Drug Compounding Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Animal Drug Compounding Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Animal Drug Compounding Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Animal Drug Compounding Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Animal Drug Compounding Consumption Forecast by Type (2022-2027) 15.3.2 Global Animal Drug Compounding Revenue Forecast by Type (2022-2027) 15.3.3 Global Animal Drug Compounding Price Forecast by Type (2022-2027) 15.4 Global Animal Drug Compounding Consumption Volume Forecast by Application (2022-2027) 15.5 Animal Drug Compounding Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology